Navigating the Intersection of Hypertension and Erectile Dysfunction: Advances in Diagnosis, Treatment, and Lifestyle Management
Article Sidebar
Main Article Content
Abstract
This comprehensive review explores the intricate relationship between hypertension and erectile dysfunction (ED), shedding light on the shared risk factors and underlying physiological mechanisms that connect these two conditions. With a focus on recent advancements, the review discusses diagnostic techniques, lifestyle modifications, medical management, and the complex interplay between antihypertensive medications and ED. It highlights the promise of pelvic computed tomography angiography (CTA) in identifying the vascular origins of ED and the potential of endovascular therapy.
The importance of lifestyle changes, including smoking cessation, weight management, and dietary adjustments, in improving both hypertension and erectile function is emphasized. The review also delves into the nuanced effects of various antihypertensive drugs on erectile function, offering a balanced perspective for clinicians and patients. Overall, this review underscores the evolving landscape of ED management and the potential for personalized treatment strategies that address not only symptoms but also the root causes of these conditions, ultimately enhancing both cardiovascular health and sexual well-being.
Metrics
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
All open access articles published in the journal are distributed under the terms of the CC-BY-NC-SA 4.0 license (Creative Commons Attribution-Non-commercial 4.0 International License) which permits unrestricted use, distribution, and reproduction in any medium, for non-commercial purposes, provided the original work is properly cited. Under Creative Commons, authors retain copyright in their articles.
References
Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith SC Jr, Spencer CC, Stafford RS, Taler SJ, Thomas RJ, Williams KA Sr, Williamson JD, Wright JT Jr. 2017 ACC/AHA/AAPA/ABC/ACPM/ AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 2018;71:e13–e115.
Centers for Disease Control and Prevention. Hypertension Cascade: Hypertension Prevalence, Treatment and Control Estimates Among US Adults Aged 18 Years and Older Applying the Criteria from the American College of Cardiology and American Heart Association’s 2017 Hypertension Guideline. US Department of Health and Human Services: Atlanta, GA, 2019.
Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, Chiuve SE, Cushman M, Delling FN, Deo R, de Ferranti SD, Ferguson JF, Fornage M, Gillespie C, Isasi CR, Jiménez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Lutsey PL, Mackey JS, Matchar DB, Matsushita K, Mussolino ME, Nasir K, O’Flaherty M, Palaniappan LP, Pandey A, Pandey DK, Reeves MJ, Ritchey MD, Rodriguez CJ, Roth GA, Rosamond WD, Sampson UKA, Satou GM, Shah SH, Spartano NL, Tirschwell DL, Tsao CW, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2018 update: a report from the American Heart Association. Circulation 2018; 137:e67–e492.
Nunes KP, Labazi H, Webb RC. New insights into hypertensionassociated erectile dysfunction. Curr Opin Nephrol Hypertens 2012;21:163–170.
Kloner R. Erectile dysfunction and hypertension. Int J Impot Res 2007;19:296–302.
Sperling J, Nilsson PM. Does early life programming influence arterial stiffness and central hemodynamics in adulthood? J Hypertens.2020;38(3):481-488.
Nilsson PM, Lurbe E, Laurent S. The early life origins of vascular ageing and cardiovascular risk: the EVA syndrome. J Hypertens.2008;26(6):1049-1057.
Doumas M, Tsakiris A, Douma S, et al. Beneficial effects of switching from beta-blockers to nebivolol on the erectile function of hypertensive patients. Asian J Androl. 2006;8(2):177-182.
Zhang Y, Jia L, Zhang Y, Ji W, Li H. Angiotensin II silencing alleviateserectile dysfunction through down-regulating the Rhoa/Rho kinase signaling pathway in rats with diabetes mellitus. Cell Physiol Biochem 2018; 45:419–427
Grunewald ZI, Jurrissen TJ, Woodford ML, Ramirez-Perez FI, Park LK, Pettit-Mee R, Ghiarone T, Brown SM, Morales-Quinones M, Ball JR, Staveley-O’Carroll KF, Aroor AR, Fadel PJ, Paradis P, Schiffrin EL, Bender SB, Martinez-Lemus LA, Padilla J. Chronic elevation of endothelin-1 alone may not be sufficient to impair endothelium dependent relaxation. Hypertension 2019; 74:1409–1419
Wu F, Xiong ZQ, Mao SH, Hu JM, Wang JQ, Jiang HW, Ding Q. Aldosterone induces inflammatory cytokines in penile corpus cavernosum by activating the NF-κB pathway. Asian J Androl 2018; 20:24–29
Musicki B, Liu T, Lagoda GA, Strong TD, Sezen SF, Johnson JM, Burnett AL. Hypercholesterolemia-induced erectile dysfunction: endothelial nitric oxide synthase (eNOS) uncoupling in the mouse penis by NAD(P)H oxidase. J Sex Med 2010; 7:3023–3032
Dongó E, Beliczai-Marosi G, Dybvig AS, Kiss L. The mechanism of action and role of hydrogen sulfide in the control of vascular tone. Nitric Oxide 2018; 81:75–87.
Da Costa Gonçalves AC, Leite R, Fraga-Silva RA, Pinheiro S V., Reis AB, Reis FM, Touyz RM, Webb RC, Alenina N, Bader M, Santos RAS. Evidence that the vasodilator angiotensin-(1–7)-Mas axis plays an important role in erectile function. Am J Physiol Heart Circ Physiol 2007; 293:2588–2596.
da Costa RM, Rodrigues D, Pereira CA, Silva JF, Alves JV, Lobato NS, Tostes RC. Nrf2 as a potential mediator of cardiovascular risk in metabolic diseases. Front Pharmacol 2019; 10:382
Sikka SC, Hellstrom WJ, Brock G, Morales AM. Standardization of vascular assessment of erectile dysfunction: standard operating procedures for duplex ultrasound. J Sex Med. 2013;10(1):120-129.
Philip F, Shishehbor M, Desai M, Schoenhagen P, Ellis S, Kapadia S. Characterization of internal pudendal artery atherosclerosis using aortography and multi-detector computed angiography. Catheter Cardiovasc Interv. 2013;82(4):E516-E521.
Kawanishi Y, Lee KS, Kimura K, Kojima K, Yamamoto A, Numata A. Feasibility of multi-slice computed tomography in the diagnosis of arteriogenic erectile dysfunction. BJU Int. 2001;88(4):390-395.
Wang TD, Lee WJ, Yang SC, et al. Clinical and imaging outcomes up to 1 year following balloon angioplasty for isolated penile artery stenoses in patients with erectile dysfunction: the PERFECT-2 study. J Endovasc Ther. 2016;23(6):867-877
Gupta BP, Murad MH, Clifton MM, Prokop L, Nehra A, Kopecky SL. The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis. Arch Intern Med. 2011;171(20):1797-1803.
Estruch R, Ros E, Salas-Salvadó J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013;368(14):1279-1290.
Diehm N, Do DD, Keo HH, et al. Early recoil after balloon angioplasty of erection-related arteries in patients with arteriogenic erectile dysfunction. J Endovasc Ther. 2018;25(6):710-715.
Rogers JH, Goldstein I, Kandzari DE, et al. Zotarolimus-eluting peripheral stents for the treatment of erectile dysfunction in subjects with suboptimal response to phosphodiesterase-5 inhibitors. J Am Coll Cardiol. 2012;60(25):2618-2627.
Wang TD. Commentary: angioplasty of internal pudendal and penile arteries for arteriogenic erectile dysfunction: reassuring, but the jury is still out. J Endovasc Ther. 2018;25(6):716-718
Chrysant SG. Antihypertensive therapy causes erectile dysfunction. Curr Opin Cardiol 2015; 30:383–390.
Münzel T, Gori T. Nebivolol: the somewhat-different beta-adrenergic receptor blocker. J Am Coll Cardiol 2009; 54:1491–1499.
Pickering T. Safety of VIAGRAS (sildenafil citrate) in men with erectile dysfunction and arterial hypertension who are taking multiple antihypertensive treatments. Am J Hypertens 2002; 15: A55–A56.
McMahon CN, Smith CJ, Shabsigh R. Treating erectile dysfunction when PDE5 inhibitors fail. BMJ 2006; 332:589–592